ArticleBiomedical optics express2022
Deep attentive convolutional neural network for automatic grading of imbalanced diabetic retinopathy in retinal fundus images.
Article in Biomedical optics express, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- In-depth analysis of research hotspots and emerging trends in AI for retinal diseases over the past decade.Frontiers in medicine · 2024Pooled it
- PDC-DETR: a Parallel Dilated Convolutional Detection Transformer for preliminary screening of multiple macular degeneration.BMC medical imaging · 2025Article
- Multi-task deep learning framework combining CNN: vision transformers and PSO for accurate diabetic retinopathy diagnosis and lesion localization.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Automated fine-grained diabetic retinopathy (DR) grading was of great significance for assisting ophthalmologists in monitoring DR and designing tailored treatments for patients. Nevertheless, it is a challenging task as a result of high intra-class variations, high inter-class similarities, small lesions, and imbalanced data distributions. The pivotal factor for the success in fine-grained DR grading is to discern more subtle associated lesion features, such as microaneurysms (MA), Hemorrhages (HM), soft exudates (SE), and hard exudates (HE). In this paper, we constructed a simple yet effective deep attentive convolutional neural network (DACNN) for DR grading and lesion discovery with only image-wise supervision. Designed as a top-down architecture, our model incorporated stochastic atrous spatial pyramid pooling (sASPP), global attention mechanism (GAM), category attention mechanism (CAM), and learnable connected module (LCM) to better extract lesion-related features and maximize the DR grading performance. To be concrete, we devised sASPP combining randomness with atrous spatial pyramid pooling (ASPP) to accommodate the various scales of the lesions and struggle against the co-adaptation of multiple atrous convolutions. Then, GAM was introduced to extract class-agnostic global attention feature details, whilst CAM was explored for seeking class-specific distinctive region-level lesion feature information and regarding each DR severity grade in an equal way, which tackled the problem of imbalance DR data distributions. Further, the LCM was designed to automatically and adaptively search the optimal connections among layers for better extracting detailed small lesion feature representations. The proposed approach obtained high accuracy of 88.0% and kappa score of 88.6% for multi-class DR grading task on the EyePACS dataset, respectively, while 98.5% AUC, 93.8% accuracy, 87.9% kappa, 90.7% recall, 94.6% precision, and 92.6% F1-score for referral and non-referral classification on the Messidor dataset. Extensive experimental results on three challenging benchmarks demonstrated that the proposed approach achieved competitive performance in DR grading and lesion discovery using retinal fundus images compared with existing cutting-edge methods, and had good generalization capacity for unseen DR datasets. These promising results highlighted its potential as an efficient and reliable tool to assist ophthalmologists in large-scale DR screening.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.